Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.

A specific two-site ELISA for human epidermal growth factor (hEGF) has been used to measure urinary hEGF/creatinine ratios in 30 normal subjects, 30 hospital in-patients with breast cancer and 30 hospital in-patients with colonic or rectal cancer. There was no significant difference between patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweetenham, J. W., Davies, D. E., Warnes, S., Alexander, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971436/
https://www.ncbi.nlm.nih.gov/pubmed/2206955
_version_ 1782134909390815232
author Sweetenham, J. W.
Davies, D. E.
Warnes, S.
Alexander, P.
author_facet Sweetenham, J. W.
Davies, D. E.
Warnes, S.
Alexander, P.
author_sort Sweetenham, J. W.
collection PubMed
description A specific two-site ELISA for human epidermal growth factor (hEGF) has been used to measure urinary hEGF/creatinine ratios in 30 normal subjects, 30 hospital in-patients with breast cancer and 30 hospital in-patients with colonic or rectal cancer. There was no significant difference between patients with breast cancer and controls. Although a statistically significant difference between patients with colorectal cancer and controls was observed, the biological significance of this observation is doubtful. No clear effect of the presence of breast or colorectal carcinoma on the urinary excretion of hEGF has been observed.
format Text
id pubmed-1971436
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19714362009-09-10 Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum. Sweetenham, J. W. Davies, D. E. Warnes, S. Alexander, P. Br J Cancer Research Article A specific two-site ELISA for human epidermal growth factor (hEGF) has been used to measure urinary hEGF/creatinine ratios in 30 normal subjects, 30 hospital in-patients with breast cancer and 30 hospital in-patients with colonic or rectal cancer. There was no significant difference between patients with breast cancer and controls. Although a statistically significant difference between patients with colorectal cancer and controls was observed, the biological significance of this observation is doubtful. No clear effect of the presence of breast or colorectal carcinoma on the urinary excretion of hEGF has been observed. Nature Publishing Group 1990-09 /pmc/articles/PMC1971436/ /pubmed/2206955 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Sweetenham, J. W.
Davies, D. E.
Warnes, S.
Alexander, P.
Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
title Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
title_full Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
title_fullStr Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
title_full_unstemmed Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
title_short Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
title_sort urinary epidermal growth factor (hegf) levels in patients with carcinomas of the breast, colon and rectum.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971436/
https://www.ncbi.nlm.nih.gov/pubmed/2206955
work_keys_str_mv AT sweetenhamjw urinaryepidermalgrowthfactorhegflevelsinpatientswithcarcinomasofthebreastcolonandrectum
AT daviesde urinaryepidermalgrowthfactorhegflevelsinpatientswithcarcinomasofthebreastcolonandrectum
AT warness urinaryepidermalgrowthfactorhegflevelsinpatientswithcarcinomasofthebreastcolonandrectum
AT alexanderp urinaryepidermalgrowthfactorhegflevelsinpatientswithcarcinomasofthebreastcolonandrectum

Ejemplares similares